1. Koutsandrea CN, Apostolopoulos MN, Alonistiotis DA, et al. Indocyanine green-assisted epiretinal membrane peeling evaluated by optical coherence tomography and multifocal electroretinography. Clin Ophthalmol. 2007; 1:535–544.
2. Klein R, Klein BE, Wang Q, Moss SE. The epidemiology of epiretinal membranes. Trans Am Ophthalmol Soc. 1994; 92:403–425.
3. Mitchell P, Smith W, Chey T, et al. Prevalence and associations of epiretinal membranes. The Blue Mountains Eye Study, Australia. Ophthalmology. 1997; 104:1033–1040.
4. Machemer R. The surgical removal of epiretinal macular membranes (macular puckers) (author's transl). Klin Monbl Augenheilkd. 1978; 173:36–42.
5. Margherio RR, Cox MS Jr, Trese MT, et al. Removal of epimacular membranes. Ophthalmology. 1985; 92:1075–1083.
6. McDonald HR, Verre WP, Aaberg TM. Surgical management of idiopathic epiretinal membranes. Ophthalmology. 1986; 93:978–983.
7. Yooh HS, Brooks HL Jr, Capone A Jr, et al. Ultrastructural features of tissue removed during idiopathic macular hole surgery. Am J Ophthalmol. 1996; 122:67–75.
8. Kim TW, Song SJ, Chung H, Yu HG. Internal limiting membrane peeling in surgical treatment of macular epiretinal membrane. J Korean Ophthalmol Soc. 2005; 46:989–994.
9. Park DW, Dugel PU, Garda J, et al. Macular pucker removal with and without internal limiting membrane peeling: pilot study. Ophthalmology. 2003; 110:62–64.
10. Kim SH, Chung JW, Chung H, Yu HG. Phacoemulsification and foldable intraocular lens implantation combined with vitrectomy and silicone oil tamponade for severe proliferative diabetic retinopathy. J Cataract Refract Surg. 2004; 30:1721–1726.
11. Kuhn F, Mester V, Berta A. The Tano Diamond Dusted Membrane Scraper: indications and contraindications. Acta Ophthalmol Scand. 1998; 76:754–755.
12. Hattenbach LO, Springer-Wanner C, Hoerauf H, et al. Intravitreal sustained-release steroid implants for the treatment of macular edema following surgical removal of epiretinal membranes. Ophthalmologica. 2017; 237:232–237.
13. Chylack LT Jr, Wolfe JK, Singer DM, et al. The Lens Opacities Classification System III. The Longitudinal Study of Cataract Study Group. Arch Ophthalmol. 1993; 111:831–836.
14. Kawasaki R, Wang JJ, Mitchell P, et al. Racial difference in the prevalence of epiretinal membrane between Caucasians and Asians. Br J Ophthalmol. 2008; 92:1320–1324.
15. Kwok AK, Lai TY, Li WW, et al. Indocyanine green-assisted internal limiting membrane removal in epiretinal membrane surgery: a clinical and histologic study. Am J Ophthalmol. 2004; 138:194–199.
16. Sivalingam A, Eagle RC Jr, Duker JS, et al. Visual prognosis correlated with the presence of internal-limiting membrane in histopathologic specimens obtained from epiretinal membrane surgery. Ophthalmology. 1990; 97:1549–1552.
17. Jang SY, Choi KS, Lee SJ. Remained macular edema after surgical treatment in patients with epiretinal membrane. J Korean Ophthalmol Soc. 2009; 50:1657–1660.
18. Lewis JM, Park I, Ohji M, et al. Diamond-dusted silicone cannula for epiretinal membrane separation during vitreous surgery. Am J Ophthalmol. 1997; 124:552–554.
19. Ray S, D'Amico DJ. Pseudophakic cystoid macular edema. Semin Ophthalmol. 2002; 17:167–180.
20. Kim SJ, Martin DF, Hubbard GB 3rd, et al. Incidence of postvitrectomy macular edema using optical coherence tomography. Ophthalmology. 2009; 116:1531–1537.
21. Johnson MW. Tractional cystoid macular edema: a subtle variant of the vitreomacular traction syndrome. Am J Ophthalmol. 2005; 140:184–192.
22. Johnson MW. Etiology and treatment of macular edema. Am J Ophthalmol. 2009; 147:11–21.
23. Hattenbach LO, Kuhli-Hattenbach C, Springer C, et al. Intravitreal dexamethasone implant for treatment of persistent postoperative macular edema after vitrectomy. Ophthalmologe. 2016; 113:581–588.
24. Klamann A, Böttcher K, Ackermann P, et al. Intravitreal dexamethasone implant for the treatment of postoperative macular edema. Ophthalmologica. 2016; 236:181–185.
25. Miyake K, Ibaraki N. Prostaglandins and cystoid macular edema. Surv ophthalmology. 2002; 47 Suppl 1:S203–S218.
26. Xu H, Chen M, Forrester JV, Lois N. Cataract surgery induces retinal pro-inflammatory gene expression and protein secretion. Invest Ophthalmol Vis Sci. 2011; 52:249–255.
27. Tranos PG, Wickremasinghe SS, Stangos NT, et al. Macular edema. Surv ophthalmology. 2004; 49:470–490.
28. Arevalo JF, Maia M, Garcia-Amaris RA, et al. Intravitreal bevacizumab for refractory pseudophakic cystoid macular edema: the Pan-American Collaborative Retina Study Group results. Ophthalmology. 2009; 116:1481–1487. 1487.e1
29. Daruich A, Matet A, Moulin A, et al. Mechanisms of macular edema: beyond the surface. Prog Retin Eye Res. 2018; 63:20–68.